GSK chief reiterates standalone consumer unit is an option

DAVOS, Switzerland (Reuters) - GlaxoSmithKline's chief executive, under pressure from some investors to break up the group, said on Thursday the drugmaker's large consumer healthcare unit had the potential to be a standalone unit at some stage.